Cytokine signatures of Plasmodium vivax infection during pregnancy and delivery outcomes.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
05 2020
Historique:
received: 05 11 2019
accepted: 19 02 2020
revised: 14 05 2020
pubmed: 5 5 2020
medline: 18 7 2020
entrez: 5 5 2020
Statut: epublish

Résumé

Plasmodium vivax malaria is a neglected disease, particularly during pregnancy. Severe vivax malaria is associated with inflammatory responses but in pregnancy immune alterations make it uncertain as to what cytokine signatures predominate, and how the type and quantity of blood immune mediators influence delivery outcomes. We measured the plasma concentrations of a set of thirty-one biomarkers, comprising cytokines, chemokines and growth factors, in 987 plasma samples from a cohort of 572 pregnant women from five malaria-endemic tropical countries and related these concentrations to delivery outcomes (birth weight and hemoglobin levels) and malaria infection. Samples were collected at recruitment (first antenatal visit) and at delivery (periphery, cord and placenta). At recruitment, we found that P. vivax-infected pregnant women had higher plasma concentrations of proinflammatory (IL-6, IL-1β, CCL4, CCL2, CXCL10) and TH1-related cytokines (mainly IL-12) than uninfected women. This biomarker signature was essentially lost at delivery and was not associated with birth weight nor hemoglobin levels. Antiinflammatory cytokines (IL-10) were positively associated with infection and poor delivery outcomes. CCL11 was the only biomarker to show a negative association with P. vivax infection and its concentration at recruitment was positively associated with hemoglobin levels at delivery. Birth weight was negatively associated with peripheral IL-4 levels at delivery. Our multi-biomarker multicenter study is the first comprehensive one to characterize the immunological signature of P. vivax infection in pregnancy thus far. In conclusion, data show that while TH1 and pro-inflammatory responses are dominant during P. vivax infection in pregnancy, antiinflammatory cytokines may compensate excessive inflammation avoiding poor delivery outcomes, and skewness toward a TH2 response may trigger worse delivery outcomes. CCL11, a chemokine largely neglected in the field of malaria, emerges as an important marker of exposure or mediator in this condition.

Identifiants

pubmed: 32365058
doi: 10.1371/journal.pntd.0008155
pii: PNTD-D-19-01839
pmc: PMC7224570
doi:

Substances chimiques

Cytokines 0
IL1B protein, human 0
Interleukin-1beta 0
Interleukin-10 130068-27-8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008155

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Infect Dis. 1999 Dec;180(6):1987-93
pubmed: 10558956
Placenta. 2018 Sep;69:1-8
pubmed: 30213477
Am J Obstet Gynecol. 2011 Mar;204(3):223.e1-5
pubmed: 21376162
Malar J. 2010 Jan 13;9:13
pubmed: 20070895
Immunol Rev. 1989 Dec;112:49-70
pubmed: 2575074
J Immunol. 2015 Apr 1;194(7):3275-85
pubmed: 25725110
J Parasit Dis. 2014 Jun;38(2):143-7
pubmed: 24808641
Malar J. 2010 Dec 14;9:361
pubmed: 21156052
Mol Immunol. 2018 May;97:82-93
pubmed: 29602073
Lancet Infect Dis. 2018 Apr;18(4):e107-e118
pubmed: 29396010
J Immunol. 1998 Mar 1;160(5):2523-30
pubmed: 9498798
J Infect Dis. 2003 Oct 1;188(7):1074-82
pubmed: 14513430
Immunol Today. 1999 Nov;20(11):500-4
pubmed: 10529777
Eur J Immunol. 2008 Oct;38(10):2697-705
pubmed: 18825754
PLoS Negl Trop Dis. 2016 Oct 6;10(10):e0005009
pubmed: 27711158
J Immunol. 2014 Sep 15;193(6):2971-83
pubmed: 25135831
Mem Inst Oswaldo Cruz. 2014 Apr;109(2):154-62
pubmed: 24676654
Front Immunol. 2017 Feb 17;8:163
pubmed: 28261219
Am J Trop Med Hyg. 1995 Nov;53(5):532-8
pubmed: 7485713
PLoS Negl Trop Dis. 2017 Jun 12;11(6):e0005606
pubmed: 28604825
J Immunol. 2003 Mar 1;170(5):2759-64
pubmed: 12594307
Cytokine. 2020 Jan;125:154818
pubmed: 31514106
Malar J. 2017 Jan 24;16(1):42
pubmed: 28118834
Trends Parasitol. 2011 Apr;27(4):168-75
pubmed: 21377424
Infect Immun. 2008 Apr;76(4):1678-85
pubmed: 18250175
PLoS One. 2013 Aug 14;8(8):e73360
pubmed: 23967342
J Infect Dis. 2012 Dec 15;206(12):1904-10
pubmed: 23053630

Auteurs

Carlota Dobaño (C)

ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.

Azucena Bardají (A)

ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.

Myriam Arévalo-Herrera (M)

Caucaseco Scientific Research Center, Cali, Colombia.

Flor E Martínez-Espinosa (FE)

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus-AM, Brazil.
Instituto Leônidas e Maria Deane, Adrianópolis, Manaus, Brazil.

Camila Bôtto-Menezes (C)

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus-AM, Brazil.
Universidade do Estado do Amazonas, Cachoeirinha, Manaus-AM, Brazil.

Norma Padilla (N)

Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala, Guatemala.

Michela Menegon (M)

Istituto Superiore di Sanità, Rome, Italy.

Swati Kochar (S)

SP Medical College, PBM Hospital, Bikaner, India.

Sanjay Kumar Kochar (SK)

SP Medical College, PBM Hospital, Bikaner, India.

Holger Unger (H)

Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea.

Maria Ome-Kaius (M)

Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea.

Anna Rosanas-Urgell (A)

Papua New Guinea Institute of Medical Research, Madang, Papua New Guinea.
Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.

Adriana Malheiros (A)

Instituto de Ciências Biológicas, Universidade Federal do Amazonas, Manaus-AM, Brazil.

Maria Eugenia Castellanos (ME)

Centro de Estudios en Salud, Universidad del Valle de Guatemala, Guatemala, Guatemala.

Dhiraj Hans (D)

International Center for Genetic Engineering and Biotechnology, New Delhi, India.

Meghna Desai (M)

Malaria Branch, Division of Parasitic Diseases and Malaria, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Aina Casellas (A)

ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.

Chetan E Chitnis (CE)

International Center for Genetic Engineering and Biotechnology, New Delhi, India.
Malaria Parasite Biology and Vaccines Unit, Institut Pasteur, Paris, France.

Carlo Severini (C)

Istituto Superiore di Sanità, Rome, Italy.

Ivo Mueller (I)

Walter and Eliza Hall Institute, Parkville, VIC, Australia.

Stephen Rogerson (S)

University of Melbourne, Parkville, VIC, Australia.

Clara Menéndez (C)

ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.

Pilar Requena (P)

ISGlobal, Hospital Clínic-Universitat de Barcelona, Barcelona, Catalonia, Spain.
Universidad de Granada, Departamento de Medicina Preventiva y Salud Pública, Facultad de Farmacia, Granada, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH